Literature DB >> 8121803

Megabase-scale analysis of the origin of N-myc amplicons in human neuroblastomas.

K Akiyama1, N Kanda, M Yamada, K Tadokoro, T Matsunaga, Y Nishi.   

Abstract

In order to elucidate the initiation of the N-myc gene amplification, we have analyzed the original structures of the N-myc amplicons among 38 human neuroblastomas. Nineteen DNAs isolated from the N-myc amplicons recognized a continuous stretch totally encompassing a 5.5 megabase region spanning the normal N-myc gene. The co-amplification profiles with these DNAs showed that two of them, which mapped into a 300 kb region flanking the N-myc gene, were commonly amplified in most specimens, while others were differentially amplified among various subsets. These profiles enabled us to divide the N-myc amplicons into several groups and outline their original domains as a continuous stretches, pointing to the existence of 'consensus sites' for the ends of the initial domains in the original region. In one cell line, the domain was found to be several times larger than that of the derivative amplicon; and the rearranged sites identified within the amplicons, which showed no site specificity, were consistent with those deduced from the domain structure. These results lead to a model in which N-myc gene amplification is initiated at some consensus sites by a preferential mechanism and followed by a random loss of the domain structures during subsequent stages.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8121803      PMCID: PMC307770          DOI: 10.1093/nar/22.2.187

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  30 in total

1.  Distinguishing characteristics of a new neuroblastoma cell line.

Authors:  J T Casper; J M Trent; J Harb; V Piaskowski; M Helmsworth; J Finlan; D D Von Hoff
Journal:  Cancer Genet Cytogenet       Date:  1983-10

2.  5-Methylcytosine is not detectable in Saccharomyces cerevisiae DNA.

Authors:  J H Proffitt; J R Davie; D Swinton; S Hattman
Journal:  Mol Cell Biol       Date:  1984-05       Impact factor: 4.272

3.  Specific DNA sequence amplification in human neuroblastoma cells.

Authors:  K T Montgomery; J L Biedler; B A Spengler; P W Melera
Journal:  Proc Natl Acad Sci U S A       Date:  1983-09       Impact factor: 11.205

4.  Isolation of amplified DNA sequences from IMR-32 human neuroblastoma cells: facilitation by fluorescence-activated flow sorting of metaphase chromosomes.

Authors:  N Kanda; R Schreck; F Alt; G Bruns; D Baltimore; S Latt
Journal:  Proc Natl Acad Sci U S A       Date:  1983-07       Impact factor: 11.205

5.  Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage.

Authors:  G M Brodeur; R C Seeger; M Schwab; H E Varmus; J M Bishop
Journal:  Science       Date:  1984-06-08       Impact factor: 47.728

6.  Structural organization of MYCN amplicons of neuroblastoma tumors, xenografts, and cell lines characterized by the sequences encompassing the MYCN amplicons in a human neuroblastoma cell line.

Authors:  K Akiyama; N Kanda; M Yamada; M Kato; K Tadokoro; T Matsunaga; Y Nishi
Journal:  Genes Chromosomes Cancer       Date:  1993-09       Impact factor: 5.006

7.  Amplified DNA with limited homology to myc cellular oncogene is shared by human neuroblastoma cell lines and a neuroblastoma tumour.

Authors:  M Schwab; K Alitalo; K H Klempnauer; H E Varmus; J M Bishop; F Gilbert; G Brodeur; M Goldstein; J Trent
Journal:  Nature       Date:  1983 Sep 15-21       Impact factor: 49.962

8.  Transposition and amplification of oncogene-related sequences in human neuroblastomas.

Authors:  N E Kohl; N Kanda; R R Schreck; G Bruns; S A Latt; F Gilbert; F W Alt
Journal:  Cell       Date:  1983-12       Impact factor: 41.582

9.  A novel chromosome abnormality in human neuroblastoma and antifolate-resistant Chinese hamster cell lives in culture.

Authors:  J L Biedler; B A Spengler
Journal:  J Natl Cancer Inst       Date:  1976-09       Impact factor: 13.506

10.  Abnormalities of chromosome 1p in human neuroblastoma tumors and cell lines.

Authors:  F Gilbert; G Balaban; P Moorhead; D Bianchi; H Schlesinger
Journal:  Cancer Genet Cytogenet       Date:  1982-09
View more
  4 in total

1.  Clinical implications of a slight increase in the gene dosage of MYCN in neuroblastoma determined using quantitative PCR.

Authors:  Ryota Souzaki; Tatsuro Tajiri; Mayumi Higashi; Yoshiaki Kinoshita; Sakura Tanaka; Kenichi Kohashi; Masazumi Tsuneyoshi; Tomoaki Taguchi
Journal:  Pediatr Surg Int       Date:  2008-10       Impact factor: 1.827

2.  Gene amplification in PNETs/medulloblastomas: mapping of a novel amplified gene within the MYCN amplicon.

Authors:  M C Frühwald; M S O'Dorisio; L J Rush; J L Reiter; D J Smiraglia; G Wenger; J F Costello; P S White; R Krahe; G M Brodeur; C Plass
Journal:  J Med Genet       Date:  2000-07       Impact factor: 6.318

3.  Genes proximal and distal to MYCN are highly expressed in human neuroblastoma as visualized by comparative expressed sequence hybridization.

Authors:  Cornelia Stock; Eva Bozsaky; Franz Watzinger; Ulrike Poetschger; Lukas Orel; Thomas Lion; Agata Kowalska; Peter F Ambros
Journal:  Am J Pathol       Date:  2007-12-28       Impact factor: 4.307

4.  Glioblastoma proto-oncogene SEC61gamma is required for tumor cell survival and response to endoplasmic reticulum stress.

Authors:  Zheming Lu; Lei Zhou; Patrick Killela; Ahmed B Rasheed; Chunhui Di; William E Poe; Roger E McLendon; Darell D Bigner; Christopher Nicchitta; Hai Yan
Journal:  Cancer Res       Date:  2009-11-17       Impact factor: 12.701

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.